# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-25-015469
Filing Date
2025-04-24
Accepted
2025-04-24 16:34:44
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-04-24

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ef20047899_ars.pdf | ARS | 1252562
| Complete submission text file | 0001140361-25-015469.txt |  | 1726657

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-23186 | Film No.: 25867871
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)